Synonyms: AZD-3759 | AZD3759 | compound 1m [PMID: 26313252]
zorifertinib is an approved drug
Compound class:
Synthetic organic
Comment: Zorifertinib (AZD3759) is an investigational EGFR tyrosine kinase inhibitor [1]. It is potent, orally active and brain-penetrant. AZD3759 was designed to target brain metastases in patients with advanced EGFR-driven lung cancer, in particular tumours harbouring EGFRL858R or EGFR-exon 19 deletion.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel